Finally, it is also possible that molecules that interfere with the interaction of GHSR1a with MRAP2 could reduce ghrelin action centrally to treat obesity without having deleterious cardiovascular effects. This evidence concerns the gene GHRL and obesity due to melanocortin 4 receptor deficiency.